Price Alert

Marrone Bio Innovations I... (MBII)

NASDAQ: MBII · Real-Time Price · USD

0.80

-0.20 (-20.00%)

At close: Apr 24, 2025, 3:47 PM

Marrone Bio Innovations Statistics

Share Statistics

Marrone Bio Innovations has 0 shares outstanding. The number of shares has increased by 4.03% in one year.

Shares Outstanding	n/a
Shares Change (YoY)	4.03%
Shares Change (QoQ)	0.93%
Owned by Institutions (%)	n/a
Shares Floating	88.51M
Failed to Deliver (FTD) Shares	n/a
FTD / Avg. Volume	n/a

Short Selling Information

The latest short interest is 1.81M, so 0% of the outstanding shares have been sold short.

Short Interest	1.81M
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.18

Valuation Ratios

The PE ratio is -7.61 and the forward PE ratio is null. Marrone Bio Innovations's PEG ratio is 0.

PE Ratio	-7.61
Forward PE	n/a
PS Ratio	2.84
Forward PS	n/a
PB Ratio	4.25
P/FCF Ratio	-11.39
PEG Ratio	0

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Marrone Bio Innovations.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.94, with a Debt / Equity ratio of 1.26.

Current Ratio	0.94
Quick Ratio	0.75
Debt / Equity	1.26
Debt / EBITDA	-3.61
Debt / FCF	-3.39
Interest Coverage	-9.52

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$289.61K
Profits Per Employee	$-108.2K
Employee Count	153
Asset Turnover	0.51
Inventory Turnover	1.98

Taxes

Income Tax	45K
Effective Tax Rate	-0.27%

Stock Price Statistics

The stock price has increased by 0.24% in the last 52 weeks. The beta is 0.36, so Marrone Bio Innovations's price volatility has been higher than the market average.

Beta	0.36
52-Week Price Change	0.24%
50-Day Moving Average	1.07
200-Day Moving Average	n/a
Relative Strength Index (RSI)	32.81
Average Volume (20 Days)	873,211

Income Statement

In the last 12 months, Marrone Bio Innovations had revenue of 44.31M and earned -16.55M in profits. Earnings per share was -0.09.

Revenue	44.31M
Gross Profit	27.25M
Operating Income	-14.94M
Net Income	-16.55M
EBITDA	-10.37M
EBIT	-14.94M
Earnings Per Share (EPS)	-0.09

Full Income Statement

Balance Sheet

The company has 19.62M in cash and 37.49M in debt, giving a net cash position of -17.87M.

Cash & Cash Equivalents	19.62M
Total Debt	37.49M
Net Cash	-17.87M
Retained Earnings	-357.37M
Total Assets	n/a
Working Capital	n/a

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -9.96M and capital expenditures -1.09M, giving a free cash flow of -11.05M.

Operating Cash Flow	-9.96M
Capital Expenditures	-1.09M
Free Cash Flow	-11.05M
FCF Per Share	-0.06

Full Cash Flow Statement

Margins

Gross margin is 61.49%, with operating and profit margins of -33.71% and -37.36%.

Gross Margin	61.49%
Operating Margin	-33.71%
Pretax Margin	-37.26%
Profit Margin	-37.36%
EBITDA Margin	-23.41%
EBIT Margin	-33.71%
FCF Margin	-24.95%

Dividends & Yields

MBII does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

Currently there are no analyst rating for MBII.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a